Consumer Health

Consumer health is registering healthy growth rates in Oman in 2023. Growth is being driven by the increasing presence of OTC brands, increasing consumer awareness, an expanding population and an increase in self-medication. Easing inflationary…

Pakistan’s economy continues to struggle and the government secured a further USD3 billion bailout with the IMF in July 2023, avoiding an impending default. Inflation continues to be very high and is being driven by several factors, including…

Consumer health sales grew moderately in 2023 as consumers prioritised their spending on essential goods over preventive health. As a result, vitamins and dietary supplements and weight management and wellbeing were the most affected. However, sports…

Consumer health declined in volume sales while retail value sales grew below inflation in 2023. This was mainly due to significant falls in the vitamins and dietary supplements and weight management and wellbeing categories while sports nutrition and…

Consumer health shows variable recovery in 2023, with an ongoing return to the normalisation of sales patterns following the atypical period of the pandemic. Challenges, however, continue, such as the departure of President Castillo's government, in…

The consumer health industry in Poland registered a decline in constant value terms in 2023, following the static performance of the previous year. This was against a backdrop of rising inflation, exacerbated by the conflict in neighbouring Ukraine,…

Overall, consumer health in Portugal is set to record strong growth in retail volume and current value terms in 2023. Demand has remained robust, as local consumers remain health-conscious and are becoming increasingly knowledgeable about the…

Consumer health registered strong sales growth in Qatar in 2023 thanks to strong purchasing power and rising interest in leading healthy lifestyles. The country’s high obesity rate has combined with the sharpened focus on health and wellbeing that…

Despite ongoing economic instability and the high rate of inflation, the consumer health market in Romania is witnessing steady growth in 2023. Notably, it is the categories of vitamin and dietary supplements, cough, cold and allergy (hay fever)…

Consumer health is set to maintain solid current value growth in 2023, with increases across most categories. Analgesics, and cough, cold and allergy (hey fever) remedies are expected to remain the largest OTC categories. Due to their maturity and…

The second half of 2022 and the first half of 2023 saw declining demand for many areas of OTC healthcare. This was linked to high inflation and the related decline in disposable incomes. Consumers have turned away from buying non-essential products…

With the threat of the pandemic leaving people’s minds in 2023, growth in consumer health in Singapore is set to stabilise, due to the gradual normalisation of consumers’ lives. With the majority of the population vaccinated, and COVID-19 likened to…

Consumer health in Slovakia is affected by changes in purchasing behaviour as a result of the fading Coronavirus (COVID-19) pandemic, the effects of the war in Ukraine and a cost of living crisis amid high inflation. However, the issue of high…

Due to the war in Ukraine, increasing energy and production costs, and the ongoing impact of COVID-19, prices have inflated significantly in Slovenia. This has been the primary reason for high current retail value growth in 2023. Levels of retail…

During the review period, many consumers have been facing financial difficulties as the cost of living in South Africa has been increasing on a monthly basis. For many consumers, their health is an afterthought with most instead prioritising…

The self-medication trend is growing in South Korea, supporting further sales growth for analgesics, and cough, cold and allergy (hay fever) remedies, especially since the prevalence of the “tripledemic” in the country, consisting of COVID-19,…

Retail volume sales of some consumer health products in 2023 are declining following a surge in demand the previous year when pandemic-related restrictions in April 2022 resulted in Spaniards returning to some extent to their pre-pandemic lives. This…

During the pandemic Sri Lanka received international support to purchase the necessary medication to help them fight COVID-19. However, due to the current economic crisis the Government of Sri Lanka has had to impose import restrictions due to…

The Swedish market consumer health saw healthy growth in retail current value terms in 2023, continuing the trend of the previous year. However, this was driven mainly by inflationary pressures, rather than any real upturn in demand. While the rate…

Consumer health witnessed a solid performance in 2023, with current value growth gaining momentum for the fourth consecutive year. Overall there has been little change in the price of OTC products, despite the slightly higher inflation rate in 2023,…

Consumer health in Taiwan has performed positively on the whole in 2023, with growth in total current value sales remaining robust and most categories either expanding in volume terms or contracting at a slower pace than in 2022. The easing of the…

In 2023, Tanzania faces high inflation and living costs, causing consumers to favour lower-priced generic medications over pricey international brands. Essential categories, such as analgesics, cough, cold, allergy remedies, and digestive remedies,…

The market for consumer health products in Thailand continued to enjoy healthy growth in current value terms in 2023. This was driven, to a large extent, by the revival of normal pre-pandemic patterns of behaviour, including the return of consumers…

In 2022, consumer health in the Czech Republic was challenged by medicine shortages, which, to some degree, continued in Q1 2023. The lack of some medicines in the Czech Republic and throughout Europe was caused by the disruption of global supply…

The Coronavirus (COVID-19) pandemic had a major impact on almost every category within consumer health in the Netherlands. While the COVID-19 situation eased by 2022, 2023 is the first full year after the pandemic in which players, retailers and…

Positive sales growth was registered across most categories of consumer health in the Philippines in 2023 as the strong focus on health and wellbeing that has spread among the population since the peak of the COVID-19 pandemic continued to spur…

2023 is set to be a strong year for consumer health in the United Arab Emirates. Many categories are expected to see robust current value growth, underpinned by an increase in online distribution channels, as well as an increasingly savvy,…

Consumer health continues to experience high retail current value growth in 2023, albeit at a slower rate than 2022. Higher costs of materials, ingredients and services are naturally leading to strong price increases in 2023, thereby driving up value…

While 2022 was characterised by high inflation, persisting supply chain constraints, and the ongoing war in Ukraine, which brought price increases and volume declines across much of consumer health, it benefited from waning COVID-19 cases and the…

Consumer health in Tunisia is facing a complex landscape characterised by several factors in 2023. Firstly, the global economic crisis has had a significant impact on the demand for consumer health products. With the cost of living rising sharply due…

Economic instability, characterised by very high inflation, continues to restrain retail volume sales at the end of the review period. The Turkish economy is taking longer than many other countries to recover from the economic effects of Coronavirus…

Uganda’s economy saw real GDP growth of 5% in 2023 and this provided a boost to sales of some consumer health products. Self-medication is driving growth in consumer health in Uganda as consumers are finding it easier and cheaper to purchase…

The picture is fairly positive in 2023, with constant value sales expected to rise slightly and inflationary pressure easing. However, rising prices are still an issue and the overall economy is expected to register a slowdown in growth.

Consumer health in 2023 is exhibiting solid current value growth as the impact of the COVID-19 pandemic diminishes. With the resurgence of seasonal ailments, categories such as cough, cold and allergy (hay fever) remedies and analgesics are…

Current value sales of consumer health in Vietnam continue to record strong growth in line with the rising trend of health and wellness in the country. Post-pandemic, the majority of Vietnamese consumers are taking greater care of their health, and…

While coughs, colds and the flu were less prevalent during the home seclusion of 2020, negatively impacting sales of cough and cold remedies in this year, they returned in full in the 2022/2023 winter season, with society fully reopened, boosting…

In mid-March 2021, Euromonitor International published revised Q1 forecasts for consumer health in the context of a slightly more positive macroeconomic outlook. The implications of this revision are expected to be muted for consumer health, as it is…

Expectations for the global consumer health industry have improved slightly for Q2 2021. Improved macroeconomic forecasts due to widening vaccination rates in markets such as the US will benefit consumer health, especially as consumers emerge from…

In mid-July 2020, Euromonitor published revised forecasts for Consumer Health in the wake of the Coronavirus pandemic. On the whole, Coronavirus (COVID-19) is expected to somewhat suppress global growth of Consumer Health in 2020, but the effects are…

In the upcoming years, consumers and businesses face an array of challenges, with income inequality, mass migration and rising uncertainty about another crisis being among the major ones. Nevertheless, within this lie untapped opportunities. This…

Cough, cold and allergy (hay fever) remedies are expected to perform better in 2023 than in the previous year, with positive value and volume growth. As life in Algeria returns to normal, and social contact increases, there is increased coughs, colds…

Retail sales of cough, cold and allergy (hay fever) remedies saw another year of healthy growth in constant value terms in 2023. With the resumption of pre-pandemic lifestyles, including a return to work, school and social activities, consumers…

Australia has been impacted by an extended season of colds and flu in 2023, with many Australians becoming ill. As the lockdowns and COVID-19 restrictions were lifted, people no longer followed social distancing, and fewer Australians have been…

Cough, cold and allergy (hay fever) remedies received a strong sales boost in 2022 due to consumers returning to working in the office more frequently again and kids returning to in-school classes. This led to consumers spending more time among other…

As COVID-19 restrictions lift and society returns to face-to-face interaction, the regular seasonal sicknesses —colds and flus—are making their own return to Azerbaijan. More social mingling means not just handshakes and hugs on the rise; sniffling…

Sales of cough, cold and allergy (hay fever) remedies are seeing strong growth in current value terms in 2023. This is partly due to inflation-driven price increases (also the consequence of supply shortages in some cases) and an increase in cough,…

Seasonal flus have returned, as people mix together once again , post pandemic, and cough, cold and allergy (hay fever remedies) are expected to register moderate current value growth, though constant value growth will be minimal, as rising costs hit…

Cough, cold and allergy (hay fever) continues to rebound following the declines during the COVID-19 pandemic and the slow recovery in its aftermath. Unit prices have been driven up by inflation resulting in double-digit current value growth in 2023,…

In 2023, cough, cold and allergy (hay fever) remedies is set to maintain dynamic current value growth in Brazil. In this year, the conclusion of the Public Health Emergency of International Concern (PHEIC) for COVID-19, as declared by the World…

Price sensitivity among Bulgarian consumers is a key factor influencing their purchasing decisions when it comes to cough, cold, and allergy (hay fever) remedies. As the minimum wage in Bulgaria is just under EUR400 in 2023, a significant portion of…